- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.10. | Basking Biosciences Names Dr. Julia Owens as CEO | ||
| 22.10. | Charles River, Francis Crick Institute Develop Antibody-Drug Conjugate | ||
| 22.10. | Alkermes to Acquire Avadel Pharmaceuticals for $2.1 Billion | ||
| 21.10. | Ajinomoto Bio-Pharma, Gene Tools Partner to Broaden Access to PMOs | ||
| 21.10. | Adare Expands Pessano Facility in Milan | ||
| 21.10. | Newleos Therapeutics Appoints Timothy Noyes as President & CEO | ||
| 21.10. | Ventus Therapeutics & Genentech Enter Collaboration | ||
| 21.10. | Galapagos Considers Winding Down Cell Therapy Business | ||
| 20.10. | Ashland Expands Portfolio of High Purity Sugar Excipients | ||
| 20.10. | Mosaic Therapeutics Taps Thomas Fuchs as CEO | ||
| 20.10. | Orsini Launches Integrated Specialty Pharmacy & 3PL Solution | ||
| 20.10. | ABT Expands Global Presence and Agarose Resins Capabilities | ||
| 20.10. | ACG to Invest $200M in U.S. Empty-Capsule Manufacturing Operations | ||
| 20.10. | Charles River, X-Chem Enter Strategic Collaboration | ||
| 20.10. | Merck Begins Construction of $3B Pharmaceutical Manufacturing Facility in VA | ||
| 17.10. | Savara Promotes Dr. Yasmine Wasfi to Chief Medical Officer | ||
| 16.10. | Cytek Biosciences Expands with New Facility in Amsterdam | ||
| 16.10. | EVOQ Therapeutics and Sanofi Enter Collaboration and License Agreement | ||
| 16.10. | Immunai to Advance Inflammatory Bowel Disease Target with AstraZeneca | ||
| 16.10. | Calico Appoints Philip R. Kym Head of Drug Discovery | ||
| 16.10. | Viatris Acquires Aculys Pharma | ||
| 15.10. | Nona Biosciences Appoints Dr. Di Hong CEO | ||
| 15.10. | Qpex Biopharma Names New President | ||
| 15.10. | MilliporeSigma to Acquire the Chromatography Business of JSR Life Sciences | ||
| 14.10. | BioCryst to Acquire Astria Therapeutics in $700 Million Deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .